Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on June 16th, 2014% (NIH.gov)
16 June 2014. A spin-off company from Kings College London in the U.K. is developing a technology that makes treating tooth cavities a painless electrical process. Reminova Ltd. — located in Perth, Scotland — was founded earlier this year and is led by two Kings College dental faculty, Nigel Pitts and Chris . . . → Read More: Spin-Off Company Develops Drill-Less Tooth Cavity Treatment
By Alan, on June 16th, 2014% Acute myeloid leukemia cells (Cancer Genome Atlas)
16 June 2014. Agios Pharmaceuticals Inc. in Cambridge, Massachusetts says the U.S. Food and Drug Administration designated its therapy for acute myelogenous leukemia an orphan drug, qualifying it for tax incentives and other benefits. The orphan drug status comes at the same time of new findings . . . → Read More: FDA Grants Experimental Leukemia Drug Orphan Status
By Alan, on June 5th, 2014% (A. Kotok)
We’ll be traveling for a few days, to explore a few other interests, and recharge our batteries. Science & Enterprise will resume on Monday 16 June.
* * *
By Alan, on June 5th, 2014% Scanning electron micrograph image of MRSA bacteria (Janice Haney Carr, Centers for Disease Control and Prevention)
5 June 2014. Researchers at Duke University in Durham, North Carolina and the Medicines Company in Parsippany, New Jersey show in a late-stage clinical trial that a single dose of the antibiotic oritavancin works as well in . . . → Read More: Trial Shows Single-Dose Antibiotic Effective with MRSA
By Alan, on June 4th, 2014% ParentGuardian screen with stress-control message (Univ of California, San Diego)
4 June 2014. Computer scientists at University of California in San Diego and Microsoft Research designed a system for smartphones and tablets providing immediate research-based guidance for parents to control their stress. The team led by San Diego engineering Ph.D. candidate Laura Pina, . . . → Read More: Mobile App/Sensor Designed to Help Parents Control Stress
By Alan, on June 4th, 2014% (Wikimedia Commons)
4 June 2014. Trevi Therapeutics Inc., a biotechnology company in New Haven, Connecticut developing therapies for chronic itching conditions, secured $15 million in its second venture financing round. The funding, the first installment in a projected $25 million round, was led by current investor TPG Biotech and includes current angel investors . . . → Read More: Clinical-Stage Biotech Lands $15M in Early Venture Funding
By Alan, on June 3rd, 2014% Chih-Chau Hwang, left, holding a vial of the polymer material that captures carbon dioxide, with James Tour (Jeff Fitlow, Rice University)
3 June 2014. Chemists and materials scientists at Rice University in Houston developed a material that inexpensively extracts and captures carbon dioxide, or CO2, from natural gas wells at ambient temperatures. The . . . → Read More: Polymer CO2-Capture Material Devised for Natural Gas Wells
By Alan, on June 3rd, 2014% (Kevin Dooley/Flickr)
3 June 2014. A joint project of the University of California campuses in San Diego and Irvine aims to answer technical and policy questions needed to collect health-related data from mobile devices and social networks for public health research. The Health Data Exploration Network project received a $1.9 million grant from the . . . → Read More: Project Underway to Enable Mobile Health Data Collection
By Alan, on June 2nd, 2014% 3-D brain wiring illustration (NIH)
2 June 2014. Mayo Clinic in Rochester, Minnesota and University of Pennsylvania in Philadelphia are seeking through an open competition new techniques to detect epilepsy seizures sooner and more accurately. The Seizure Detection Challenge has a total prize purse of $8,000 and a deadline for submissions of 19 . . . → Read More: Challenge Seeks Methods to More Accurately Detect Epilepsy
By Alan, on June 2nd, 2014% (HealthyPeople.gov)
2 June 2014. Quest Diagnostics in Madison, New Jersey and Memorial Sloan Kettering Cancer Center in New York are developing tests to give physicians more precise data on genetic causes of solid tumor cancers, such as breast, prostate, colon, and lung cancer. Financial and intellectual property aspects of the collaboration were not . . . → Read More: Quest, Sloan Kettering Partner on Solid Tumor Diagnostics
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.